Table 4.
Event rates per 100 patient-years for CKD patients diagnosed in 2017 without HF at baseline and followed for 24 months
| Events | Stage 1 (n = 95) | Stage 2 (n = 335) | Stage 3a (n = 522) | Stage 3b (n = 402) | Stage 4 (n = 116) | Stage 5 (n = 49) | Unspecified (n = 75) | Total CKD (N = 1594) |
|---|---|---|---|---|---|---|---|---|
| All-cause death, n (event rate) Time to first event (days) |
7 (3.9) 516.0 |
26 (4.2) 482.2 |
44 (4.5) 450.7 |
36 (4.9) 405.6 |
11 (5.3) 369.1 |
5 (5.7) 343.3 |
6 (4.0) 484.2 |
135 (4.9) 429.2 |
| Heart failure, n (event rate) Time to first event (days) |
5 (2.6) 317.5 |
18 (2.8) 288.7 |
29 (3.0) 269.8 |
24 (3.3) 248.2 |
8 (3.5) 223.4 |
3 (3.8) 203.3 |
4 (2.6) 309.1 |
91 (3.2) 287.0 |
| CKD, n (event rate) Time to first event (days) |
3 (1.8) 479.1 |
12 (2.0) 447.7 |
20 (2.1) 426.4 |
18 (2.3) 396.6 |
5 (2.5) 356.9 |
3 (2.8) 324.8 |
3 (2.0) 463.4 |
64 (2.6) 394.8 |
| Myocardial infarction, n (event rate) Time to first event (days) |
5 (2.6) 423.3 |
17 (2.8) 403.1 |
28 (2.9) 366.5 |
23 (3.2) 337.1 |
7 (3.4) 316.9 |
3 (3.7) 288.4 |
4 (2.6) 396.7 |
87 (3.4) 336.2 |
| Stroke, n (event rate) Time to first event (days) |
4 (2.1) 390.7 |
14 (2.3) 368.6 |
24 (2.5) 338.2 |
21 (2.8) 314.5 |
7 (3.0) 292.5 |
3 (3.2) 272.0 |
3 (2.1) 364.5 |
76 (2.9) 363.6 |
| PAD, n (event rate) Time to first event (days) |
2 (1.1) 359.9 |
8 (1.2) 342.8 |
13 (1.3) 320.4 |
10 (1.4) 304.3 |
3 (1.6) 277.0 |
2 (1.7) 249.3 |
2 (1.2) 358.4 |
40 (1.3) 299.4 |
| Albuminuria (UACR ≥30 mg/g), n (event rate) Time to first event (days) |
2 (1.0) 521.5 |
7 (1.1) 492.0 |
11 (1.2) 455.6 |
10 (1.3) 410.0 |
3 (1.4) 389.5 |
1 (1.4) 350.6 |
1 (1.1) 496.6 |
35 (1.3) 429.8 |
| Albuminuria (UACR ≥300 mg/g), n (event rate) Time to first event (days) |
1 (0.5) 562.2 |
3 (0.5) 525.4 |
6 (0.6) 491.0 |
5 (0.6) 446.8 |
1 (0.6) 411.1 |
1 (0.7) 386.4 |
1 (0.5) 516.6 |
18 (0.7) 446.4 |
PAD, peripheral artery disease.